Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy

Author： Ahirwar Dinesh Agrahari Anita Mandhani Anil Mittal Rama

ISSN： 1366-5804

Source： Biomarkers, Vol.14, Iss.4, 2009-06, pp. : 213-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53 intron 7 polymorphisms in urinary bladder cancer patients and controls

By Steineck G.

Mutagenesis, Vol. 15, Iss. 1, 2000-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite

ERCC2/XPD gene polymorphisms and cancer risk

By Benhamou S.

Mutagenesis, Vol. 17, Iss. 6, 2002-11 ,pp. : 463-469

Oxford University Press

Access to resources Recommend Favorite

Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population

By Klimčáková Lucia Habalová Viera Sivoňová Monika Nagy Vincent Šalagovič Ján Židzik Jozef

Molecular Biology Reports, Vol. 38, Iss. 2, 2011-02 ,pp. : 1287-1293

Springer Publishing Company

Access to resources Recommend Favorite

No Association Between Base Excision Repair Gene Polymorphisms and Risk of Lung Cancer

By Vogel Ulla Nexø Bjørn A. Wallin Håkan Overvad Kim Tjønneland Anne Raaschou-Nielsen Ole

Biochemical Genetics, Vol. 42, Iss. 11-12, 2004-12 ,pp. : 453-460

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapy of cancer by IL-12-based cytokine combinations

By Weiss Jonathan M Subleski Jeff J Wigginton Jon M Wiltrout Robert H

Expert Opinion on Biological Therapy, Vol. 7, Iss. 11, 2007-11 ,pp. : 1705-1721

Informa Healthcare

Access to resources Recommend Favorite